Related references
Note: Only part of the references are listed.Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)
Taro Shibuki et al.
BMC CANCER (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation
Gerard M. Healy et al.
EUROPEAN RADIOLOGY (2022)
The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer
Alexander Muehlberg et al.
EUROPEAN RADIOLOGY (2021)
Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer
G. C. Deng et al.
BMC CANCER (2021)
nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation
Fabian Isensee et al.
NATURE METHODS (2021)
Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
Leonie Gebauer et al.
CANCERS (2021)
CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma
Seyoun Park et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2021)
Pancreatic Cancer: A Review
Wungki Park et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy
Emmanuel Salinas-Miranda et al.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES (2021)
Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection
Tiansong Xie et al.
EUROPEAN RADIOLOGY (2020)
SciPy 1.0: fundamental algorithms for scientific computing in Python
Pauli Virtanen et al.
NATURE METHODS (2020)
CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging
Yucheng Zhang et al.
BMC MEDICAL IMAGING (2020)
Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy
Elsa Parr et al.
CANCERS (2020)
CT texture analysis of pancreatic cancer
Kumar Sandrasegaran et al.
EUROPEAN RADIOLOGY (2019)
Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy
Si-Hang Cheng et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
Deep learning-based survival prediction of oral cancer patients
Dong Wook Kim et al.
SCIENTIFIC REPORTS (2019)
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan
Lorenzo Fornaro et al.
CLINICAL COLORECTAL CANCER (2019)
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma
Luca Cozzi et al.
PLOS ONE (2019)
A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer
Haidy Nasief et al.
NPJ PRECISION ONCOLOGY (2019)
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis
Marc A. Attiyeh et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: association with survival outcomes after curative resection
Gabin Yun et al.
SCIENTIFIC REPORTS (2018)
Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real-world study
Junjie Hang et al.
CANCER MEDICINE (2018)
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
Ana Fernandez et al.
BMC CANCER (2018)
The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients
Matteo Piciucchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis
Hani Oweira et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis
Armin Eilaghi et al.
BMC MEDICAL IMAGING (2017)
Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients
Jayasree Chakraborty et al.
PLOS ONE (2017)
Computational Radiomics System to Decode the Radiographic Phenotype
Joost J. M. van Griethuysen et al.
CANCER RESEARCH (2017)
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
Dewi Vernerey et al.
BRITISH JOURNAL OF CANCER (2016)
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
Barbara Bournet et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy
Peng Xue et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Anorexia-cachexia syndrome in pancreatic cancer: Recent advances and new pharmacological approach
Ilaria Ronga et al.
ADVANCES IN MEDICAL SCIENCES (2014)
Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy
T. Hamada et al.
BRITISH JOURNAL OF CANCER (2014)
Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
Faruk Tas et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
M. Stotz et al.
BRITISH JOURNAL OF CANCER (2013)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
Takeshi Ogura et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Prognostic Model to Predict Clinical Outcomes with First-Line Gemcitabine-Based Chemotherapy in Advanced Pancreatic Cancer
Jun Ho Yi et al.
ONCOLOGY (2011)
RANDOM SURVIVAL FORESTS
Hemant Ishwaran et al.
ANNALS OF APPLIED STATISTICS (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas:: lack of mutations in the BRAF and EGFR genes
Heike Immervoll et al.
VIRCHOWS ARCHIV (2006)
Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer
Paul Glen et al.
PANCREATOLOGY (2006)
CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials
NR Maisey et al.
BRITISH JOURNAL OF CANCER (2005)
Share Paper
